Umbilical Cord Stem Cell Lysate: A New Biologic Injectate for the Putative Treatment of Acute Temporomandibular Joint Inflammation

References

• Wang XD, Zhang JN, Gan YN, et al. Current understanding of pathogenesis and treatment of TMJ osteoarthritis. J Dent Res. 2015;94(5):666–673. doi:10.1177/0022034515574770
   PubMed Web of Science ®Google Scholar
• Cui D, Li H, Xu X, et al. Mesenchymal stem cells for cartilage regeneration of TMJ osteoarthritis. Stem Cells Int. 2017;2017(2017):5979741. doi:10.1155/2017/5979741
   PubMedGoogle Scholar
• Arinci A, Ademoglu E, Aslan A, et al. Molecular correlates of temporomandibular joint disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;99(6):666–670. doi:10.1016/j.tripleo.2004.08.029
   PubMed Web of Science ®Google Scholar
• Liapaki A, Thamm JR, Ha S, et al. Is there a difference in treatment effect of different intra-articular drugs for temporomandibular joint osteoarthritis? A systematic review of randomized controlled trials. Int J Oral Maxillofac Surg. 2021;50(9):1233–1243. PMID: 33642154. doi:10.1016/j.ijom.2021.01.019
   PubMed Web of Science ®Google Scholar
• Wernecke C, Braun HJ, Dragoo JL. The effect of intra-articular corticosteroids on articular cartilage: a systematic review. Orthop J Sports Med. 2015;3(5):2325967115581163. PMID: 26674652; PMCID: PMC4622344. doi:10.1177/2325967115581163
   PubMed Web of Science ®Google Scholar
• El-Hakim IE, Abdel-Hamid IS, Bader A. Temporomandibular joint (TMJ) response to intra-articular dexamethasone injection following mechanical arthropathy: a histological study in rats. Int J Oral Maxillofac Surg. 2005;34(3):305–310. doi:10.1016/j.ijom.2004.05.004
   PubMed Web of Science ®Google Scholar
• Hegab AF, Ali HE, Elmasry M, Khallaf MG. Platelet-rich plasma injection as an effective treatment for temporomandibular joint osteoarthritis. J Oral Maxillofac Surg. 2015;73(9):1706–1713. PMID: 25882438. doi:10.1016/j.joms.2015.03.045
   PubMed Web of Science ®Google Scholar
• Bouloux GF, Chou J, Krishnan D, et al. Is hyaluronic acid or corticosteroid superior to lactated ringer solution in the short-term reduction of temporomandibular joint pain after arthrocentesis? Part 1. J Oral Maxillofac Surg. 2017;75(1):52–62. PMID: 27632069. doi:10.1016/j.joms.2016.08.006
   PubMed Web of Science ®Google Scholar
• Chung PY, Lin MT, Chang HP. Effectiveness of platelet-rich plasma injection in patients with temporomandibular joint osteoarthritis: a systematic review and meta-analysis of randomized controlled trials. Oral Surg Oral Med Oral Pathol Oral Radiol. 2019;127(2):106–116. PMID: 30449691. doi:10.1016/j.oooo.2018.09.003
   PubMed Web of Science ®Google Scholar
• Bousnaki M, Bakopoulou A, Koidis P. Platelet-rich plasma for the therapeutic management of temporomandibular joint disorders: a systematic review. Int J Oral Maxillofac Surg. 2018;47(2):188–198. PMID: 29066000. doi:10.1016/j.ijom.2017.09.014
   PubMed Web of Science ®Google Scholar
• Luk F, de Witte SF, Wm B, et al. Efficacy of immunotherapy with mesenchymal stem cells in man: a systematic review. Expert Rev Clin Immunol. 2015;11(5):617–636. doi:10.1586/1744666X.2015.1029458
   PubMed Web of Science ®Google Scholar
• Zhu C, Wu W, Qu X. Mesenchymal stem cells in osteoarthritis therapy: a review. Am J Transl Res. 2021;13(2):448–461.
   PubMed Web of Science ®Google Scholar
• Wakitani S, Okabe T, Horibe S, et al. Safety of autologous bone marrow-derived mesenchymal stem cell transplantation for cartilage repair in 41 patients with 45 joints followed for up to 11 years and 5 months. J Tissue Eng Regen Med. 2011;5(2):146–150. doi:10.1002/term.299
   PubMed Web of Science ®Google Scholar
• Gong S, Emperumal CP, Enciso R, Enciso R. Regeneration of temporomandibular joint using in vitro human stem cells: a review. J Tissue Eng Regen Med. 2022;16(7):591–604. doi:10.1002/term.3302
   PubMed Web of Science ®Google Scholar
• Saad FA, Abdellah AM. Does stem cells approach ameliorate the prospective alterations of mandibular joint histology and acetylcholinesterase expression in experimentally induced alzheimer’s disease? Egypt J Histol. 2021;44(2):349–367.
   Google Scholar
• Köhnke R, Ahlers MO, Birkelbach MA, et al. Temporomandibular joint osteoarthritis: regenerative treatment by a stem cell containing advanced therapy medicinal product (ATMP)- An in vivo animal trial. Int J Mol Sci. 2021;22(1):443. doi:10.3390/ijms22010443
   PubMed Web of Science ®Google Scholar
• Patel R, Kong D, Eisig SB, et al. Improving TMJ Regeneration. JOMS. 2013;71(9):E25–26. doi:10.1016/j.joms.2013.06.046
   Google Scholar
• Zhou Y, Xei L. An update on mesenchymal stem cell-centered therapies in temporomandibular joint arthritis. Stem Cells Int. 2021;2021:1–15. doi:10.1155/2021/6619527
   Web of Science ®Google Scholar
• Lee RH, Pulin AA, Sao MJ, et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell. 2009;5(1):54–63. doi:10.1016/j.stem.2009.05.003
   PubMed Web of Science ®Google Scholar
• Barry F. MSC therapy for osteoarthritis: an unfinished story. J Orthop Res. 2019;37(6):1229–1235. doi:10.1002/jor.24343
   PubMed Web of Science ®Google Scholar
• Ankrum JA, Ong JF, Karp JM. Mesenchymal stem cells: immune evasive, not immune privileged. Nat Biotechnol. 2014;32(3):252–260. doi:10.1038/nbt.2816
   PubMed Web of Science ®Google Scholar
• Weiss DJ, English K, Krasnodembskaya A, isaza-Correa JM, Hawthorne IJ, Mahon BP. The necrobiology of mesenchymal stromal cells affects therapeutic efficacy. Front Immunol. 2019;10:1228. doi:10.3389/fimmu.2019.01228
   PubMed Web of Science ®Google Scholar
• Kim H, Yang G, Park J, Choi J, Kang E, Lee B-K. Therapeutic effect of mesenchymal stem cells derived from human umbilical cord in rabbit temporomandibular joint model of osteoarthritis. Sci Rep. 2019;9:13854. doi:10.1038/s41598-019-50435-2
   PubMed Web of Science ®Google Scholar
• Kou X, Xu X, Chen C, et al. The Fas/Fap-1/Cav-1 complex regulates Il-1RA secretion in mesenchymal stem cells to accelerate healing. Sci Transl Med. 2018;10(432). doi:10.1126/scitranslmed.aai8524
   Web of Science ®Google Scholar
• Phinney DG, Pittenger MF. Concise review: MSC-derived exosomes for cell-free therapy. Stem Cells. 2017;35(4):851–858. doi:10.1002/stem.2575
   PubMed Web of Science ®Google Scholar
• Song I, Seol DR, Kim EM, Lim T-H, Martin J, Shin K. Therapeutic effects of MSC-exosomes on fibroblasts and synoviocytes in TMJ. IADR/AADR/CADR General Session. Presentation ID 3335; Washington, D.C, USA; 2020.
   Google Scholar
• Hamidian JS, Li Y, Davies JE. Effect of tumor necrosis factor alpha dose and exposure time on tumor necrosis factor-induced gene-6 activation by neonatal and adult mesenchymal stromal cells. Stem Cells Dev. 2018;27(1):44–54. doi:10.1089/scd.2017.0179
   PubMed Web of Science ®Google Scholar
• Forbes S, Bond AR, Thirlwell KL, et al. Human umbilical cord perivascular cells improve human pancreatic islet transplant function by increasing vascularization. Sci Transl Med. 2020;12(526). doi:10.1126/scitranslmed.aan5907
   Web of Science ®Google Scholar
• Davies JE, Walker JT, Keating A. Concise review: Wharton’s jelly: the rich, but enigmatic, source of mesenchymal stromal cells. Stem Cells Transl Med. 2017;6(7):1620–1630. doi:10.1002/sctm.16-0492
   PubMed Web of Science ®Google Scholar
• L-l L, Liu Y-J, Yang S-G, et al. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica. 2006;91(8):1017–1026.
   PubMed Web of Science ®Google Scholar
• Sarugaser R, Lickorish D, Baksh D, Hosseini M, Davies JE. Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells. 2005;23(2):220–229. doi:10.1634/stemcells.2004-0166
   PubMed Web of Science ®Google Scholar
• Schugar RC, Chirieleison SM, Wescoe KE, et al. High harvest yield, high expansion, and phenotype stability of CD146 mesenchymal stromal cells from whole primitive human umbilical cord tissue. J Biomed Biotechnol. 2009;2009:789526. doi:10.1155/2009/789526
   PubMed Web of Science ®Google Scholar
• Di Rosa M, Willoughby DA. Screens for anti-inflammatory drugs. J Pharm Pharmacol. 1971;23(4):297–298. doi:10.1111/j.2042-7158.1971.tb08661.x
   PubMed Web of Science ®Google Scholar
• Henriques MG, Silva PM, Martins MA, et al. Mouse paw edema. A new model for inflammation? Braz J Med Biol Res. 1987;20(2):243–249.
   PubMed Web of Science ®Google Scholar
• Goulart AC, Dos Santos Correia FA, de Sousa SCOM, de Cerqueira Luz JG. Study of the inflammatory process induced by injection of carrageenan or formalin in the rat temporomandibular joint. Braz Oral Res. 2005;19(2):99–105. doi:10.1590/S1806-83242005000200005
   PubMedGoogle Scholar
• Sarugaser R, Ennis J, Stanford WL, Davies JE. Isolation, propagation, and characterization of Human Umbilical Cord Perivascular Cells (HUCPVCs). Methods Mol Biol. 2009;482:269–279.
   PubMedGoogle Scholar
• Fuentes R, Veuthey C, Arias A, et al. Injection in temporomandibular joint of rats. Description of technical protocol. Pol J Vet Sci. 2017;20(2):207–211. doi:10.1515/pjvs-2017-0025
   PubMed Web of Science ®Google Scholar
• Berke HL, Wilson G, Berke ES. Size distribution changes in peripheral lymphocytes of the rat after X-irradiation. Rad Res. 1969;37(1):181–191. doi:10.2307/3572762
   PubMed Web of Science ®Google Scholar
• Willoughby DA, DiRosa M. Studies on the mode of action of non-steroid anti-inflammatory drugs. Ann Rheum Dis. 1972;31(6):540. doi:10.1136/ard.31.6.540
   PubMed Web of Science ®Google Scholar
• Porto GG, Vasconcelos BC, Andrade ES, et al. Comparison between human and rat TMJ: anatomic and histopathologic features. Acta Cir Bras. 2010;25(3):290–293. doi:10.1590/S0102-86502010000300012
   PubMed Web of Science ®Google Scholar
• Winter CA, Risley EA, Nuss GW. Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs. Proc Soc Exp Biol Med. 1962;111:544–547. doi:10.3181/00379727-111-27849
   PubMed Web of Science ®Google Scholar
• Morris CJ. Carrageenan-induced paw edema in the rat and mouse. Methods Mol Biol. 2003;225:115–121. doi:10.1385/1-59259-374-7:115
   PubMedGoogle Scholar
• Radhakrishnan R, Moore SA, Sluka KA. Unilateral carrageenan injection into muscle or joint induces chronic bilateral hyperalgesia in rats. Pain. 2003;104(3):567–577. doi:10.1016/S0304-3959(03)00114-3
   PubMed Web of Science ®Google Scholar
• Loram LC, Fuller A, Gayle Fick L, Cartmell T, Poole S, Mitchell D. Cytokine profiles during carrageenan-induced inflammatory hyperalgesia in rat muscle and hind paw. J Pain. 2007;8(2):127–136. doi:10.1016/j.jpain.2006.06.010
   PubMed Web of Science ®Google Scholar
• Loram LC, Themistocleous AC, Fick LG, Kamerman PR. The time course of inflammatory cytokine secretion in a rat model of postoperative pain does not coincide with the onset of mechanical hyperalgesia. Can J Physiol Pharmacol. 2007;85(6):613–620. doi:10.1139/Y07-054
   PubMed Web of Science ®Google Scholar
• Grinnemo H, Månsson A, Dellgren G, et al. Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium. J Thorac Cardiovasc Surg. 2004;127(5):1293–1300. doi:10.1016/j.jtcvs.2003.07.037
   PubMed Web of Science ®Google Scholar
• Kwon DR, Park G-Y, Lee SC. Regenerative effects of mesenchymal stem cells by dosage in a chronic rotator cuff tendon tear in a rabbit model. Regen Med. 2019;14(11):1001–1012. doi:10.2217/rme-2018-0125
   PubMed Web of Science ®Google Scholar
• Eggenhofer E, Luk F, Dahlke MH, Hoogduijn MJ. The life and fate of mesenchymal stem cells. Front Immunol. 2014;5:148. doi:10.3389/fimmu.2014.00148
   PubMed Web of Science ®Google Scholar
• Bernardo ME, Fibbe WE. Mesenchymal stromal cells: sensors and switchers of inflammation. Cell Stem Cell. 2013;13(4):392–402. doi:10.1016/j.stem.2013.09.006
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Mougiakakos D. Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol. 2012;12(5):383–396. doi:10.1038/nri3209
   PubMed Web of Science ®Google Scholar
• Lässer C, Jang SC, Lötvall J. Subpopulations of extracellular vesicles and their therapeutic potential. Mol Aspects Med. 2018;60:1–14. doi:10.1016/j.mam.2018.02.002
   PubMed Web of Science ®Google Scholar
• Muthu S, Bapat A, Jain R, Jeyaraman N, Jeyaraman M. Exosomal therapy-a new frontier in regenerative medicine. Stem Cell Investig. 2021;8:7. doi:10.21037/sci-2020-037
   PubMedGoogle Scholar
• Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 2013;200(4):373–383. doi:10.1083/jcb.201211138
   PubMed Web of Science ®Google Scholar
• Liang W, Han B, Hai Y, Sun D, Yin P. Mechanism of action of mesenchymal stem cell-derived exosomes in the intervertebral disc degeneration treatment and bone repair and regeneration. Front Cell Dev Biol. 2022;9:833840. doi:10.3389/fcell.2021.833840
   PubMed Web of Science ®Google Scholar
• Hu JC, Zheng CX, Sui BD, Liu WJ, Jin Y. Mesenchymal stem cell-derived exosomes: a novel and potential remedy for cutaneous wound healing and regeneration. World J Stem Cells. 2022;14(5):318–329. doi:10.4252/wjsc.v14.i5.318
   PubMed Web of Science ®Google Scholar
• Jafari D, Shajari S, Jafari R, et al. Designer exosomes: a new platform for biotechnology therapeutics. BioDrugs. 2020;34:567–586. doi:10.1007/s40259-020-00434-x
   PubMed Web of Science ®Google Scholar
• Baranov MV, Kumar M, Sacanna S, Thutupalli S, van den Bogaart G. Modulation of immune responses by particle size and shape. Front Immunol. 2021;11. doi:10.3389/fimmu.2020.607945
   PubMed Web of Science ®Google Scholar
• Wang J, Chen D, Ho EA. Challenges in the development and establishment of exosome-based drug delivery systems. J Control Release. 2021;329:894–906. doi:10.1016/j.jconrel.2020.10.020
   PubMed Web of Science ®Google Scholar